• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICROVENTION, INC. AZUR CX 35 DETACHABLE; DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICROVENTION, INC. AZUR CX 35 DETACHABLE; DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION Back to Search Results
Model Number 45-751324
Medical Device Problem Code Unsealed Device Packaging (1444)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 04/12/2023
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
A search for non-conformances associated with the reported part/lot number combination did not reveal any production-related issues relevant to the complaint that occurred during manufacturing of the device.The device was reported available for return for analysis, but has not yet been received; therefore, the alleged product issue cannot be confirmed at this time.If the device or additional information is received, a supplemental report will be submitted.
 
Event or Problem Description
It was reported that the coil was selected for the embolization of the internal iliac artery.Reportedly prior to use, the coil packaging was noticed to be open.The coil was not used and the physician used other coils to successfully complete the case.There was no report of harm or injury to the patient.
 
Additional Manufacturer Narrative
Summary of device evaluation: the investigation found that the seal on the returned pouch was missing, which is consistent with the condition observed in the customer-provided images.The evaluation identified manufacturing as the cause for the incomplete seal (operator not following instructions defined on the manufacturing procedure).Further investigation concluded that the present event is related to an isolated event; there are no similar complaints based on the complaint category regarding this product family from the last two years recorded in the complaint system at the time of this investigation.Additionally, a search for non-conformances associated with this part/lot number combination did not reveal any production-related issues relevant to the complaint that occurred during manufacturing of the device.The findings from this investigation have been communicated to manufacturing operators through an awareness communication.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AZUR CX 35 DETACHABLE
Common Device Name
DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION
Manufacturer (Section D)
MICROVENTION, INC.
35 enterprise
aliso viejo CA 92656
Manufacturer Contact
terrence callahan
35 enterprise
aliso viejo, CA 92656
7142478000
MDR Report Key16825736
Report Number2032493-2023-00693
Device Sequence Number6709042
Product Code KRD
UDI-Device Identifier00812636021089
UDI-Public(01)00812636021089(11)220509(17)270430(10)0000190693
Combination Product (Y/N)N
Initial Reporter StateWA
Initial Reporter CountryUS
PMA/510(K) Number
K151358
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,User Facility,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 04/12/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number45-751324
Device Catalogue Number45-751324
Device Lot Number0000190693
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 04/12/2023
Supplement Date Received by Manufacturer07/13/2023
Initial Report FDA Received Date04/27/2023
Supplement Report FDA Received Date08/09/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured05/09/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-